OpenFilings

RELMADA THERAPEUTICS, INC.

Form10-Q

Report Period2025-03-31

Date Filed2025-05-12

Time Filed16:06:07

Document Analysis

Natural Language Processing

Recognized Type Unidentified

Defined Term Format

Exhibits

QUARTERLY REPORT
EXCLUSIVE LICENSE AGREEMENT BETWEEN TRIGONE PHARMA, LTD., AND RELMADA THERAPEUTI
CERTIFICATION
CERTIFICATION
CERTIFICATION
CERTIFICATION
Filing on SEC Edgar